Suzuken Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3398000004
JPY
6,189.00
106 (1.74%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

192.5 k

Shareholding (Sep 2018)

FII

0.00%

Held by 0 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has very low debt and has enough cash to service the debt requirements

 
2

Poor long term growth as Net Sales has grown by an annual rate of 1.63% over the last 5 years

3

With ROE of 9.07%, it has a very attractive valuation with a 1.01 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 468,311 Million (Mid Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.35

stock-summary
Return on Equity

8.87%

stock-summary
Price to Book

1.16

Revenue and Profits:
Net Sales:
592,872 Million
(Quarterly Results - Jun 2025)
Net Profit:
3,783 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.19%
0%
1.19%
6 Months
15.6%
0%
15.6%
1 Year
31.04%
0%
31.04%
2 Years
24.73%
0%
24.73%
3 Years
70.03%
0%
70.03%
4 Years
85.3%
0%
85.3%
5 Years
57.48%
0%
57.48%

Suzuken Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.63%
EBIT Growth (5y)
2.67%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.35
Sales to Capital Employed (avg)
5.73
Tax Ratio
31.39%
Dividend Payout Ratio
22.00%
Pledged Shares
0
Institutional Holding
0.39%
ROCE (avg)
11.93%
ROE (avg)
5.93%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
1.01
EV to EBIT
7.21
EV to EBITDA
5.45
EV to Capital Employed
1.01
EV to Sales
0.11
PEG Ratio
0.51
Dividend Yield
NA
ROCE (Latest)
13.97%
ROE (Latest)
9.07%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2018stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 1.83% vs 1.49% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -23.73% vs 48.73% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "592,872.00",
          "val2": "582,196.00",
          "chgp": "1.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8,510.00",
          "val2": "8,138.00",
          "chgp": "4.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.00",
          "val2": "9.00",
          "chgp": "11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.00",
          "val2": "-153.00",
          "chgp": "90.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,783.00",
          "val2": "4,960.00",
          "chgp": "-23.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.40%",
          "val2": "9.10%",
          "chgp": "0.03%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 0.56% vs 3.10% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 18.98% vs 42.72% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,399,952.00",
          "val2": "2,386,493.00",
          "chgp": "0.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "49,189.00",
          "val2": "43,620.00",
          "chgp": "12.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "41.00",
          "val2": "43.00",
          "chgp": "-4.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2,306.00",
          "val2": "-2,391.00",
          "chgp": "3.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "34,503.00",
          "val2": "29,000.00",
          "chgp": "18.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.50%",
          "val2": "14.60%",
          "chgp": "0.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
592,872.00
582,196.00
1.83%
Operating Profit (PBDIT) excl Other Income
8,510.00
8,138.00
4.57%
Interest
10.00
9.00
11.11%
Exceptional Items
-14.00
-153.00
90.85%
Consolidate Net Profit
3,783.00
4,960.00
-23.73%
Operating Profit Margin (Excl OI)
9.40%
9.10%
0.03%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 1.83% vs 1.49% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -23.73% vs 48.73% in Jun 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
2,399,952.00
2,386,493.00
0.56%
Operating Profit (PBDIT) excl Other Income
49,189.00
43,620.00
12.77%
Interest
41.00
43.00
-4.65%
Exceptional Items
-2,306.00
-2,391.00
3.55%
Consolidate Net Profit
34,503.00
29,000.00
18.98%
Operating Profit Margin (Excl OI)
15.50%
14.60%
0.09%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 0.56% vs 3.10% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 18.98% vs 42.72% in Mar 2024

stock-summaryCompany CV
About Suzuken Co., Ltd. stock-summary
stock-summary
Suzuken Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available